Global Specialty Generics Market Size, Share & Industry Trends Analysis Report By Type (Injectables, Oral Drugs, and Others), By Application, By End Use (Specialty Pharmacy, Retail Pharmacy, and Hospital Pharmacy), By Regional Outlook and Forecast, 2023 - 2030

The Global Specialty Generics Market size is expected to reach $141.5 billion by 2030, rising at a market growth of 9.8% CAGR during the forecast period.

Oncology is one of the major application specialty generics, thereby, it generated $10,292 million revenue in the market in 2022. Cancer will be the primary cause of nearly 10 million deaths in 2020, or close to one in every six. About 30% of cancer cases in low- and lower-middle-income nations are caused by cancer-causing diseases such as the human papillomavirus (HPV) and hepatitis. Many cancers are curable if caught early and treated successfully, but due to the adoption of a Western lifestyle, heavy alcohol and tobacco use, bad dietary habits, and lack of physical activity. The market is expected to see increased demand as cancer cases rise.

The major strategies followed by the market participants are Product Launches as the key developmental strategy to keep pace with the changing demands of end users. For instance, In January, 2023, Sun Pharmaceutical Industries rolled out the generic version of palbociclib, a breast cancer medication by Pfizer. The launch would be under the brand name Paleno, which would address the treatment requirements of several advanced breast cancer patients in India. Additionally, In July, 2022, Dr Reddy's Laboratories announced the launch of the generic version Bortezomib for Injection, the medication of Velcade brand. The product launch can be used for the treatment of certain types of cancer across the US market. The product can be delivered in a 3.5 mg per 10 mL single-dose vial presentation for subcutaneous.

KBV Cardinal Matrix - Market Competition Analysis

Based on the Analysis presented in the KBV Cardinal matrix; Novartis AG are the forerunners in the Market. In September, 2020, Novartis collaborated with the African Union through the Africa Medical Supplies Platform. This collaboration would enhance the supply of medicines from the Novartis Pandemic Response offering to the AU member states and Caricom countries. Companies such as Viatris, Inc., Dr. Reddy’s Laboratories Ltd., Teva Pharmaceuticals Industries Ltd., Fresenius SE & Co. KGaA and Hikma Pharmaceuticals PLC are some of the key innovators in the Market.

Market Growth Factors

Growing ageing population

The WHO reports that people are living longer overall. The majority of people today likely plan to live until their sixties and beyond. By 2030, one in six people will be 60 years of age or older. 1.4 billion people will be above the age of 60 by this time, up from 1 billion in 2020. By 2050, there will be 2.1 billion people in the globe who are 60 years of age or older. According to projections, there will be 426 million individuals who are 80 years of age or older by the year 2050. By 2050, low- and middle-income countries will be home to two-thirds of the world's over-60 population. The need for specialty generics will rise as people live longer and endure more severe problems like chronic illnesses and cancer.

Growing healthcare expenditures

The increasing number & size of investments invested in the healthcare industry by governments of different nations is one of the primary drivers of the market's growth. The WHO reports that healthcare spending reached a record high of US $9 trillion (about 11% of global GDP) due to substantial increases in healthcare spending by governments at all income levels. In general, rising government health spending largely offsets declining personal spending. Increasing spending in the healthcare industry has led to an increase in market innovations. The market is expanding as a result of increased investment in the healthcare industry.

Market Restraining Factors

Regulatory challenges impeding market growth

Due to their complexity or distinctive delivery methods, specialty generics may need more regulatory attention. These items may require expensive and time-consuming regulatory approval. Market entrance delays and regulatory obstacles can prevent the market from expanding. Specialty generics might not cleanly fit into current legislative or approval processes. In order to handle these complicated items, regulatory bodies may need to modify their regulations or create new procedures. This might delay the launch of specialty generics by making the approval process take longer and creating more uncertainty for producers.

Type Outlook

On the basis of type, the market is classified into injectables, oral drugs and others. In 2022, the injectables segment dominated the market with the maximum revenue share. The segment's growth can be ascribed to the advantages of injectables, such as their quick absorption and long-lasting effects, which increase patient compliance and acceptability. Drug therapies known as specialty injectable generics are available as generics and are utilized to treat chronic conditions that must be administered via infusion, injection, or inhalation. It has the same active ingredients as the branded versions of it and includes biologics that are used to treat various medications.

Application Outlook

Based on application, the market is segmented into oncology, inflammatory conditions, multiple sclerosis, hepatitis C, and others. The hepatitis C segment recorded a remarkable revenue share in the in 2022. Most hepatitis C infections result from exposure to blood from risky injection techniques, unscreened blood transfusions, risky medical procedures, injecting drugs, and sexual behaviors that expose one to blood. Around 1.5 million new cases of the hepatitis C virus are reported each year, with an estimated 58 million people worldwide carrying the infection. According to estimates, 3.2 million children and adolescents worldwide have chronic hepatitis C infection.

End use Outlook

By end use, the market is fragmented into specialty pharmacy, retail pharmacy, and hospital pharmacy. In 2022, the specialty pharmacy segment witnessed the largest revenue share in the market. Because specialty pharmacies have low distribution costs and convenient access to medications, major specialty generic manufacturers & insurance companies choose them for product distribution. In addition, in comparison to branded products, specialty generic drug inventory's low cost offers a better return on investment. Maximizing patient access, timely delivery, and efficient distribution management of specialty pharmacies all draw consumers to them and thus contribute to the expansion of this market segment.

Specialty Generics Market Report Coverage

Report Attribute	Details
Market size value in 2022	USD 67.9 Billion
Market size forecast in 2030	USD 141.5 Billion
Base Year	2022
Historical Period	2019 to 2021
Forecast Period	2023 to 2030
Revenue Growth Rate	CAGR of 9.8% from 2023 to 2030
Number of Pages	233
Number of Table	374
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling
Segments covered	Type, Application, End Use, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Growing ageing population Growing healthcare expenditures
Restraints	Regulatory challenges impeding market growth

Regional Outlook

Region wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North American region led the market by generating the highest revenue share in the market. This is due to the existence of regulatory policies that are favorable to the approval of innovative products. The American FDA has launched several attempts to streamline the entire approval procedure. Therefore, the major producers continuously work to commercialize specialty generic medicines on the market.

Free Valuable Insights: Global Specialty Generics Market size to reach USD 141.5 Billion by 2030

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teva Pharmaceuticals Industries Ltd., Novartis AG, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Fresenius SE & Co. KGaA, Dr. Reddy’s Laboratories Ltd., Mallinckrodt PLC, Bausch Health Companies, Inc., Viatris, Inc. and Apotex, Inc.

Strategies deployed in the Market

» Partnerships, Collaborations and Agreements:

• Mar-2022: Viatris Inc. partnered with Kindeva Drug Delivery L.P., a developer and manufacturer of products across a wide range of complex drug-delivery formats. Under this partnership, both companies received FDA approval for Breyna, the generic version of AstraZeneca's Symbicort. The Bryna is a drug-device combined product that is indicated for various patients with asthma or chronic obstructive pulmonary disease and would be available in 80 mcg/4.5 mcg and 160 mcg/4.5 mcg dosage strengths.
• Sep-2021: Hikma Pharmaceuticals PLC signed an agreement with FAES Farma S.A., a manufacturer, and developer of commercialized pharmaceutical products. Under this agreement, both companies would aim to market and sell Bilastine tablets which is a non-sedating second-generation antihistamine molecule for the treatment of allergic rhinitis and urticaria.

» Product Launches and Product Expansions:

• Jan-2023: Sun Pharmaceutical Industries rolled out the generic version of palbociclib, a breast cancer medication by Pfizer. The launch would be under the brand name Paleno, which would address the treatment requirements of several advanced breast cancer patients in India.
• Jan-2023: Hikma Pharmaceuticals PLC released an authorized generic version of Jazz Pharmaceuticals’ Xyrem oral solution, a prescription medicine for narcolepsy symptoms in people of 7 years or older. This launch broadens Hikma's diversified offering of generic products and emphasizes its capability to reach millions of people relying on Hikma's medicines.
• Jan-2023: Hikma Pharmaceuticals PLC rolled out the Naloxone Hydrochloride Injection, USP, 2mg/2mL, in the prefilled syringe (PFS) form across the US. This would be the third PFS product launch that can be used for the emergency treatment of a known or expected opioid overdose.
• Jul-2022: Dr Reddy's Laboratories announced the launch of the generic version Bortezomib for Injection, the medication of Velcade brand. The product launch can be used for the treatment of certain types of cancer across the US market. The product can be delivered in a 3.5 mg per 10 mL single-dose vial presentation for subcutaneous.
• Mar-2022: Teva Pharmaceuticals, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd. introduced a generic version of Revlimid1, the medication in 5mg, 10mg, 15mg, and 25mg strengths across the United States. The launched product aims to deliver patients with another key treatment alternative for highly challenging conditions, indicating Teva's adherence to making complex generic drugs accessible to patients who require a generic version of Revlimid.
• May-2021: Teva Pharmaceuticals, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd., unveiled the generic version of THIOLA tablets, the medication for use in combination with high fluid intake, alkali, and diet modification. The launched generic version is unresponsive to treatment with alkali, high fluid intake, and diet modification.

» Acquisitions and Mergers:

• Mar-2022: Fresenius completed the acquisition of mAbxience, a leading international biopharmaceutical company. The acquisition aimed at expanding its business by making cheaper versions of biotechnology drugs that have lost patent protection. Also, the acquisition would further strengthen and leverage Fresenius Kabi's position, as both perfectly complement the company's growth businesses in biopharmaceuticals & medical technology.

» Trials and Approvals:

• Sep-2022: Bausch Health Companies Inc. came into partnership with Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd. Through this partnership, both companies would unveil RYALTRIS which received approval from Health Canada for the symptomatic treatment of moderate to critical seasonal allergic rhinitis and associated ocular symptoms in children aged 6 years and more.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Injectables
• Oral Drugs
• Others

By Application

• Inflammatory conditions
• Multiple sclerosis
• Hepatitis C
• Oncology
• Others

By End Use

• Specialty Pharmacy
• Retail Pharmacy
• Hospital Pharmacy

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Teva Pharmaceuticals Industries Ltd.
• Novartis AG
• Hikma Pharmaceuticals PLC
• Sun Pharmaceutical Industries Ltd.
• Fresenius SE & Co. KGaA
• Dr. Reddy’s Laboratories Ltd.
• Mallinckrodt PLC
• Bausch Health Companies, Inc.
• Viatris, Inc.
• Apotex, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Specialty Generics Market, by Type
1.4.2 Global Specialty Generics Market, by Application
1.4.3 Global Specialty Generics Market, by End Use
1.4.4 Global Specialty Generics Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2020, May – 2023, Jan) Leading Players

Chapter 4. Global Specialty Generics Market by Type
4.1 Global Injectables Market by Region
4.2 Global Oral Drugs Market by Region
4.3 Global Others Market by Region

Chapter 5. Global Specialty Generics Market by Application
5.1 Global Inflammatory conditions Market by Region
5.2 Global Multiple sclerosis Market by Region
5.3 Global Hepatitis C Market by Region
5.4 Global Oncology Market by Region
5.5 Global Others Market by Region

Chapter 6. Global Specialty Generics Market by End Use
6.1 Global Specialty Pharmacy Market by Region
6.2 Global Retail Pharmacy Market by Region
6.3 Global Hospital Pharmacy Market by Region

Chapter 7. Global Specialty Generics Market by Region
7.1 North America Specialty Generics Market
7.1.1 North America Specialty Generics Market by Type
7.1.1.1 North America Injectables Market by Country
7.1.1.2 North America Oral Drugs Market by Country
7.1.1.3 North America Others Market by Country
7.1.2 North America Specialty Generics Market by Application
7.1.2.1 North America Inflammatory conditions Market by Country
7.1.2.2 North America Multiple sclerosis Market by Country
7.1.2.3 North America Hepatitis C Market by Country
7.1.2.4 North America Oncology Market by Country
7.1.2.5 North America Others Market by Country
7.1.3 North America Specialty Generics Market by End Use
7.1.3.1 North America Specialty Pharmacy Market by Country
7.1.3.2 North America Retail Pharmacy Market by Country
7.1.3.3 North America Hospital Pharmacy Market by Country
7.1.4 North America Specialty Generics Market by Country
7.1.4.1 US Specialty Generics Market
7.1.4.1.1 US Specialty Generics Market by Type
7.1.4.1.2 US Specialty Generics Market by Application
7.1.4.1.3 US Specialty Generics Market by End Use
7.1.4.2 Canada Specialty Generics Market
7.1.4.2.1 Canada Specialty Generics Market by Type
7.1.4.2.2 Canada Specialty Generics Market by Application
7.1.4.2.3 Canada Specialty Generics Market by End Use
7.1.4.3 Mexico Specialty Generics Market
7.1.4.3.1 Mexico Specialty Generics Market by Type
7.1.4.3.2 Mexico Specialty Generics Market by Application
7.1.4.3.3 Mexico Specialty Generics Market by End Use
7.1.4.4 Rest of North America Specialty Generics Market
7.1.4.4.1 Rest of North America Specialty Generics Market by Type
7.1.4.4.2 Rest of North America Specialty Generics Market by Application
7.1.4.4.3 Rest of North America Specialty Generics Market by End Use
7.2 Europe Specialty Generics Market
7.2.1 Europe Specialty Generics Market by Type
7.2.1.1 Europe Injectables Market by Country
7.2.1.2 Europe Oral Drugs Market by Country
7.2.1.3 Europe Others Market by Country
7.2.2 Europe Specialty Generics Market by Application
7.2.2.1 Europe Inflammatory conditions Market by Country
7.2.2.2 Europe Multiple sclerosis Market by Country
7.2.2.3 Europe Hepatitis C Market by Country
7.2.2.4 Europe Oncology Market by Country
7.2.2.5 Europe Others Market by Country
7.2.3 Europe Specialty Generics Market by End Use
7.2.3.1 Europe Specialty Pharmacy Market by Country
7.2.3.2 Europe Retail Pharmacy Market by Country
7.2.3.3 Europe Hospital Pharmacy Market by Country
7.2.4 Europe Specialty Generics Market by Country
7.2.4.1 Germany Specialty Generics Market
7.2.4.1.1 Germany Specialty Generics Market by Type
7.2.4.1.2 Germany Specialty Generics Market by Application
7.2.4.1.3 Germany Specialty Generics Market by End Use
7.2.4.2 UK Specialty Generics Market
7.2.4.2.1 UK Specialty Generics Market by Type
7.2.4.2.2 UK Specialty Generics Market by Application
7.2.4.2.3 UK Specialty Generics Market by End Use
7.2.4.3 France Specialty Generics Market
7.2.4.3.1 France Specialty Generics Market by Type
7.2.4.3.2 France Specialty Generics Market by Application
7.2.4.3.3 France Specialty Generics Market by End Use
7.2.4.4 Russia Specialty Generics Market
7.2.4.4.1 Russia Specialty Generics Market by Type
7.2.4.4.2 Russia Specialty Generics Market by Application
7.2.4.4.3 Russia Specialty Generics Market by End Use
7.2.4.5 Spain Specialty Generics Market
7.2.4.5.1 Spain Specialty Generics Market by Type
7.2.4.5.2 Spain Specialty Generics Market by Application
7.2.4.5.3 Spain Specialty Generics Market by End Use
7.2.4.6 Italy Specialty Generics Market
7.2.4.6.1 Italy Specialty Generics Market by Type
7.2.4.6.2 Italy Specialty Generics Market by Application
7.2.4.6.3 Italy Specialty Generics Market by End Use
7.2.4.7 Rest of Europe Specialty Generics Market
7.2.4.7.1 Rest of Europe Specialty Generics Market by Type
7.2.4.7.2 Rest of Europe Specialty Generics Market by Application
7.2.4.7.3 Rest of Europe Specialty Generics Market by End Use
7.3 Asia Pacific Specialty Generics Market
7.3.1 Asia Pacific Specialty Generics Market by Type
7.3.1.1 Asia Pacific Injectables Market by Country
7.3.1.2 Asia Pacific Oral Drugs Market by Country
7.3.1.3 Asia Pacific Others Market by Country
7.3.2 Asia Pacific Specialty Generics Market by Application
7.3.2.1 Asia Pacific Inflammatory conditions Market by Country
7.3.2.2 Asia Pacific Multiple sclerosis Market by Country
7.3.2.3 Asia Pacific Hepatitis C Market by Country
7.3.2.4 Asia Pacific Oncology Market by Country
7.3.2.5 Asia Pacific Others Market by Country
7.3.3 Asia Pacific Specialty Generics Market by End Use
7.3.3.1 Asia Pacific Specialty Pharmacy Market by Country
7.3.3.2 Asia Pacific Retail Pharmacy Market by Country
7.3.3.3 Asia Pacific Hospital Pharmacy Market by Country
7.3.4 Asia Pacific Specialty Generics Market by Country
7.3.4.1 China Specialty Generics Market
7.3.4.1.1 China Specialty Generics Market by Type
7.3.4.1.2 China Specialty Generics Market by Application
7.3.4.1.3 China Specialty Generics Market by End Use
7.3.4.2 Japan Specialty Generics Market
7.3.4.2.1 Japan Specialty Generics Market by Type
7.3.4.2.2 Japan Specialty Generics Market by Application
7.3.4.2.3 Japan Specialty Generics Market by End Use
7.3.4.3 India Specialty Generics Market
7.3.4.3.1 India Specialty Generics Market by Type
7.3.4.3.2 India Specialty Generics Market by Application
7.3.4.3.3 India Specialty Generics Market by End Use
7.3.4.4 South Korea Specialty Generics Market
7.3.4.4.1 South Korea Specialty Generics Market by Type
7.3.4.4.2 South Korea Specialty Generics Market by Application
7.3.4.4.3 South Korea Specialty Generics Market by End Use
7.3.4.5 Singapore Specialty Generics Market
7.3.4.5.1 Singapore Specialty Generics Market by Type
7.3.4.5.2 Singapore Specialty Generics Market by Application
7.3.4.5.3 Singapore Specialty Generics Market by End Use
7.3.4.6 Malaysia Specialty Generics Market
7.3.4.6.1 Malaysia Specialty Generics Market by Type
7.3.4.6.2 Malaysia Specialty Generics Market by Application
7.3.4.6.3 Malaysia Specialty Generics Market by End Use
7.3.4.7 Rest of Asia Pacific Specialty Generics Market
7.3.4.7.1 Rest of Asia Pacific Specialty Generics Market by Type
7.3.4.7.2 Rest of Asia Pacific Specialty Generics Market by Application
7.3.4.7.3 Rest of Asia Pacific Specialty Generics Market by End Use
7.4 LAMEA Specialty Generics Market
7.4.1 LAMEA Specialty Generics Market by Type
7.4.1.1 LAMEA Injectables Market by Country
7.4.1.2 LAMEA Oral Drugs Market by Country
7.4.1.3 LAMEA Others Market by Country
7.4.2 LAMEA Specialty Generics Market by Application
7.4.2.1 LAMEA Inflammatory conditions Market by Country
7.4.2.2 LAMEA Multiple sclerosis Market by Country
7.4.2.3 LAMEA Hepatitis C Market by Country
7.4.2.4 LAMEA Oncology Market by Country
7.4.2.5 LAMEA Others Market by Country
7.4.3 LAMEA Specialty Generics Market by End Use
7.4.3.1 LAMEA Specialty Pharmacy Market by Country
7.4.3.2 LAMEA Retail Pharmacy Market by Country
7.4.3.3 LAMEA Hospital Pharmacy Market by Country
7.4.4 LAMEA Specialty Generics Market by Country
7.4.4.1 Brazil Specialty Generics Market
7.4.4.1.1 Brazil Specialty Generics Market by Type
7.4.4.1.2 Brazil Specialty Generics Market by Application
7.4.4.1.3 Brazil Specialty Generics Market by End Use
7.4.4.2 Argentina Specialty Generics Market
7.4.4.2.1 Argentina Specialty Generics Market by Type
7.4.4.2.2 Argentina Specialty Generics Market by Application
7.4.4.2.3 Argentina Specialty Generics Market by End Use
7.4.4.3 UAE Specialty Generics Market
7.4.4.3.1 UAE Specialty Generics Market by Type
7.4.4.3.2 UAE Specialty Generics Market by Application
7.4.4.3.3 UAE Specialty Generics Market by End Use
7.4.4.4 Saudi Arabia Specialty Generics Market
7.4.4.4.1 Saudi Arabia Specialty Generics Market by Type
7.4.4.4.2 Saudi Arabia Specialty Generics Market by Application
7.4.4.4.3 Saudi Arabia Specialty Generics Market by End Use
7.4.4.5 South Africa Specialty Generics Market
7.4.4.5.1 South Africa Specialty Generics Market by Type
7.4.4.5.2 South Africa Specialty Generics Market by Application
7.4.4.5.3 South Africa Specialty Generics Market by End Use
7.4.4.6 Nigeria Specialty Generics Market
7.4.4.6.1 Nigeria Specialty Generics Market by Type
7.4.4.6.2 Nigeria Specialty Generics Market by Application
7.4.4.6.3 Nigeria Specialty Generics Market by End Use
7.4.4.7 Rest of LAMEA Specialty Generics Market
7.4.4.7.1 Rest of LAMEA Specialty Generics Market by Type
7.4.4.7.2 Rest of LAMEA Specialty Generics Market by Application
7.4.4.7.3 Rest of LAMEA Specialty Generics Market by End Use
Chapter 8. Company Profiles
8.1 Teva Pharmaceutical Industries Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.2 Novartis AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Acquisition and Mergers:
8.3 Hikma Pharmaceuticals PLC
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 Sun Pharmaceutical Industries Ltd.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.5 Fresenius SE & Co. KGaA
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Acquisition and Mergers:
8.6 Dr. Reddy’s Laboratories Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.7 Mallinckrodt PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Bausch Health Companies, Inc
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Viatris, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.10. Apotex, Inc.
8.10.1 Company Overview

TABLE 1 Global Specialty Generics Market, 2019 - 2022, USD Million
TABLE 2 Global Specialty Generics Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Specialty Generics Market
TABLE 4 Product Launches And Product Expansions– Specialty Generics Market
TABLE 5 Acquisition and Mergers– Specialty Generics Market
TABLE 6 Approvals and Trials– Specialty Generics Market
TABLE 7 Global Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 8 Global Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 9 Global Injectables Market by Region, 2019 - 2022, USD Million
TABLE 10 Global Injectables Market by Region, 2023 - 2030, USD Million
TABLE 11 Global Oral Drugs Market by Region, 2019 - 2022, USD Million
TABLE 12 Global Oral Drugs Market by Region, 2023 - 2030, USD Million
TABLE 13 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 14 Global Others Market by Region, 2023 - 2030, USD Million
TABLE 15 Global Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 16 Global Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 17 Global Inflammatory conditions Market by Region, 2019 - 2022, USD Million
TABLE 18 Global Inflammatory conditions Market by Region, 2023 - 2030, USD Million
TABLE 19 Global Multiple sclerosis Market by Region, 2019 - 2022, USD Million
TABLE 20 Global Multiple sclerosis Market by Region, 2023 - 2030, USD Million
TABLE 21 Global Hepatitis C Market by Region, 2019 - 2022, USD Million
TABLE 22 Global Hepatitis C Market by Region, 2023 - 2030, USD Million
TABLE 23 Global Oncology Market by Region, 2019 - 2022, USD Million
TABLE 24 Global Oncology Market by Region, 2023 - 2030, USD Million
TABLE 25 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 26 Global Others Market by Region, 2023 - 2030, USD Million
TABLE 27 Global Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 28 Global Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 29 Global Specialty Pharmacy Market by Region, 2019 - 2022, USD Million
TABLE 30 Global Specialty Pharmacy Market by Region, 2023 - 2030, USD Million
TABLE 31 Global Retail Pharmacy Market by Region, 2019 - 2022, USD Million
TABLE 32 Global Retail Pharmacy Market by Region, 2023 - 2030, USD Million
TABLE 33 Global Hospital Pharmacy Market by Region, 2019 - 2022, USD Million
TABLE 34 Global Hospital Pharmacy Market by Region, 2023 - 2030, USD Million
TABLE 35 Global Specialty Generics Market by Region, 2019 - 2022, USD Million
TABLE 36 Global Specialty Generics Market by Region, 2023 - 2030, USD Million
TABLE 37 North America Specialty Generics Market, 2019 - 2022, USD Million
TABLE 38 North America Specialty Generics Market, 2023 - 2030, USD Million
TABLE 39 North America Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 40 North America Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 41 North America Injectables Market by Country, 2019 - 2022, USD Million
TABLE 42 North America Injectables Market by Country, 2023 - 2030, USD Million
TABLE 43 North America Oral Drugs Market by Country, 2019 - 2022, USD Million
TABLE 44 North America Oral Drugs Market by Country, 2023 - 2030, USD Million
TABLE 45 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 46 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 47 North America Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 48 North America Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 49 North America Inflammatory conditions Market by Country, 2019 - 2022, USD Million
TABLE 50 North America Inflammatory conditions Market by Country, 2023 - 2030, USD Million
TABLE 51 North America Multiple sclerosis Market by Country, 2019 - 2022, USD Million
TABLE 52 North America Multiple sclerosis Market by Country, 2023 - 2030, USD Million
TABLE 53 North America Hepatitis C Market by Country, 2019 - 2022, USD Million
TABLE 54 North America Hepatitis C Market by Country, 2023 - 2030, USD Million
TABLE 55 North America Oncology Market by Country, 2019 - 2022, USD Million
TABLE 56 North America Oncology Market by Country, 2023 - 2030, USD Million
TABLE 57 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 58 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 59 North America Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 60 North America Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 61 North America Specialty Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 62 North America Specialty Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 63 North America Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 64 North America Retail Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 65 North America Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 66 North America Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 67 North America Specialty Generics Market by Country, 2019 - 2022, USD Million
TABLE 68 North America Specialty Generics Market by Country, 2023 - 2030, USD Million
TABLE 69 US Specialty Generics Market, 2019 - 2022, USD Million
TABLE 70 US Specialty Generics Market, 2023 - 2030, USD Million
TABLE 71 US Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 72 US Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 73 US Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 74 US Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 75 US Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 76 US Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 77 Canada Specialty Generics Market, 2019 - 2022, USD Million
TABLE 78 Canada Specialty Generics Market, 2023 - 2030, USD Million
TABLE 79 Canada Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 80 Canada Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 81 Canada Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 82 Canada Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 83 Canada Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 84 Canada Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 85 Mexico Specialty Generics Market, 2019 - 2022, USD Million
TABLE 86 Mexico Specialty Generics Market, 2023 - 2030, USD Million
TABLE 87 Mexico Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 88 Mexico Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 89 Mexico Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 90 Mexico Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 91 Mexico Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 92 Mexico Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 93 Rest of North America Specialty Generics Market, 2019 - 2022, USD Million
TABLE 94 Rest of North America Specialty Generics Market, 2023 - 2030, USD Million
TABLE 95 Rest of North America Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 96 Rest of North America Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 97 Rest of North America Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 98 Rest of North America Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 99 Rest of North America Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 100 Rest of North America Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 101 Europe Specialty Generics Market, 2019 - 2022, USD Million
TABLE 102 Europe Specialty Generics Market, 2023 - 2030, USD Million
TABLE 103 Europe Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 104 Europe Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 105 Europe Injectables Market by Country, 2019 - 2022, USD Million
TABLE 106 Europe Injectables Market by Country, 2023 - 2030, USD Million
TABLE 107 Europe Oral Drugs Market by Country, 2019 - 2022, USD Million
TABLE 108 Europe Oral Drugs Market by Country, 2023 - 2030, USD Million
TABLE 109 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 110 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 111 Europe Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 112 Europe Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 113 Europe Inflammatory conditions Market by Country, 2019 - 2022, USD Million
TABLE 114 Europe Inflammatory conditions Market by Country, 2023 - 2030, USD Million
TABLE 115 Europe Multiple sclerosis Market by Country, 2019 - 2022, USD Million
TABLE 116 Europe Multiple sclerosis Market by Country, 2023 - 2030, USD Million
TABLE 117 Europe Hepatitis C Market by Country, 2019 - 2022, USD Million
TABLE 118 Europe Hepatitis C Market by Country, 2023 - 2030, USD Million
TABLE 119 Europe Oncology Market by Country, 2019 - 2022, USD Million
TABLE 120 Europe Oncology Market by Country, 2023 - 2030, USD Million
TABLE 121 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 122 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 123 Europe Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 124 Europe Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 125 Europe Specialty Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 126 Europe Specialty Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 127 Europe Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 128 Europe Retail Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 129 Europe Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 130 Europe Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 131 Europe Specialty Generics Market by Country, 2019 - 2022, USD Million
TABLE 132 Europe Specialty Generics Market by Country, 2023 - 2030, USD Million
TABLE 133 Germany Specialty Generics Market, 2019 - 2022, USD Million
TABLE 134 Germany Specialty Generics Market, 2023 - 2030, USD Million
TABLE 135 Germany Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 136 Germany Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 137 Germany Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 138 Germany Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 139 Germany Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 140 Germany Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 141 UK Specialty Generics Market, 2019 - 2022, USD Million
TABLE 142 UK Specialty Generics Market, 2023 - 2030, USD Million
TABLE 143 UK Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 144 UK Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 145 UK Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 146 UK Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 147 UK Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 148 UK Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 149 France Specialty Generics Market, 2019 - 2022, USD Million
TABLE 150 France Specialty Generics Market, 2023 - 2030, USD Million
TABLE 151 France Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 152 France Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 153 France Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 154 France Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 155 France Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 156 France Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 157 Russia Specialty Generics Market, 2019 - 2022, USD Million
TABLE 158 Russia Specialty Generics Market, 2023 - 2030, USD Million
TABLE 159 Russia Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 160 Russia Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 161 Russia Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 162 Russia Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 163 Russia Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 164 Russia Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 165 Spain Specialty Generics Market, 2019 - 2022, USD Million
TABLE 166 Spain Specialty Generics Market, 2023 - 2030, USD Million
TABLE 167 Spain Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 168 Spain Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 169 Spain Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 170 Spain Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 171 Spain Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 172 Spain Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 173 Italy Specialty Generics Market, 2019 - 2022, USD Million
TABLE 174 Italy Specialty Generics Market, 2023 - 2030, USD Million
TABLE 175 Italy Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 176 Italy Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 177 Italy Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 178 Italy Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 179 Italy Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 180 Italy Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 181 Rest of Europe Specialty Generics Market, 2019 - 2022, USD Million
TABLE 182 Rest of Europe Specialty Generics Market, 2023 - 2030, USD Million
TABLE 183 Rest of Europe Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 184 Rest of Europe Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 185 Rest of Europe Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 186 Rest of Europe Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 187 Rest of Europe Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 188 Rest of Europe Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 189 Asia Pacific Specialty Generics Market, 2019 - 2022, USD Million
TABLE 190 Asia Pacific Specialty Generics Market, 2023 - 2030, USD Million
TABLE 191 Asia Pacific Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 192 Asia Pacific Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 193 Asia Pacific Injectables Market by Country, 2019 - 2022, USD Million
TABLE 194 Asia Pacific Injectables Market by Country, 2023 - 2030, USD Million
TABLE 195 Asia Pacific Oral Drugs Market by Country, 2019 - 2022, USD Million
TABLE 196 Asia Pacific Oral Drugs Market by Country, 2023 - 2030, USD Million
TABLE 197 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 198 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 199 Asia Pacific Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 200 Asia Pacific Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 201 Asia Pacific Inflammatory conditions Market by Country, 2019 - 2022, USD Million
TABLE 202 Asia Pacific Inflammatory conditions Market by Country, 2023 - 2030, USD Million
TABLE 203 Asia Pacific Multiple sclerosis Market by Country, 2019 - 2022, USD Million
TABLE 204 Asia Pacific Multiple sclerosis Market by Country, 2023 - 2030, USD Million
TABLE 205 Asia Pacific Hepatitis C Market by Country, 2019 - 2022, USD Million
TABLE 206 Asia Pacific Hepatitis C Market by Country, 2023 - 2030, USD Million
TABLE 207 Asia Pacific Oncology Market by Country, 2019 - 2022, USD Million
TABLE 208 Asia Pacific Oncology Market by Country, 2023 - 2030, USD Million
TABLE 209 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 210 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 211 Asia Pacific Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 212 Asia Pacific Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 213 Asia Pacific Specialty Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 214 Asia Pacific Specialty Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 215 Asia Pacific Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 216 Asia Pacific Retail Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 217 Asia Pacific Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 218 Asia Pacific Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 219 Asia Pacific Specialty Generics Market by Country, 2019 - 2022, USD Million
TABLE 220 Asia Pacific Specialty Generics Market by Country, 2023 - 2030, USD Million
TABLE 221 China Specialty Generics Market, 2019 - 2022, USD Million
TABLE 222 China Specialty Generics Market, 2023 - 2030, USD Million
TABLE 223 China Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 224 China Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 225 China Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 226 China Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 227 China Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 228 China Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 229 Japan Specialty Generics Market, 2019 - 2022, USD Million
TABLE 230 Japan Specialty Generics Market, 2023 - 2030, USD Million
TABLE 231 Japan Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 232 Japan Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 233 Japan Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 234 Japan Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 235 Japan Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 236 Japan Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 237 India Specialty Generics Market, 2019 - 2022, USD Million
TABLE 238 India Specialty Generics Market, 2023 - 2030, USD Million
TABLE 239 India Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 240 India Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 241 India Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 242 India Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 243 India Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 244 India Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 245 South Korea Specialty Generics Market, 2019 - 2022, USD Million
TABLE 246 South Korea Specialty Generics Market, 2023 - 2030, USD Million
TABLE 247 South Korea Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 248 South Korea Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 249 South Korea Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 250 South Korea Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 251 South Korea Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 252 South Korea Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 253 Singapore Specialty Generics Market, 2019 - 2022, USD Million
TABLE 254 Singapore Specialty Generics Market, 2023 - 2030, USD Million
TABLE 255 Singapore Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 256 Singapore Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 257 Singapore Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 258 Singapore Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 259 Singapore Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 260 Singapore Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 261 Malaysia Specialty Generics Market, 2019 - 2022, USD Million
TABLE 262 Malaysia Specialty Generics Market, 2023 - 2030, USD Million
TABLE 263 Malaysia Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 264 Malaysia Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 265 Malaysia Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 266 Malaysia Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 267 Malaysia Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 268 Malaysia Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 269 Rest of Asia Pacific Specialty Generics Market, 2019 - 2022, USD Million
TABLE 270 Rest of Asia Pacific Specialty Generics Market, 2023 - 2030, USD Million
TABLE 271 Rest of Asia Pacific Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 272 Rest of Asia Pacific Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 273 Rest of Asia Pacific Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 274 Rest of Asia Pacific Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 275 Rest of Asia Pacific Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 276 Rest of Asia Pacific Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 277 LAMEA Specialty Generics Market, 2019 - 2022, USD Million
TABLE 278 LAMEA Specialty Generics Market, 2023 - 2030, USD Million
TABLE 279 LAMEA Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 280 LAMEA Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 281 LAMEA Injectables Market by Country, 2019 - 2022, USD Million
TABLE 282 LAMEA Injectables Market by Country, 2023 - 2030, USD Million
TABLE 283 LAMEA Oral Drugs Market by Country, 2019 - 2022, USD Million
TABLE 284 LAMEA Oral Drugs Market by Country, 2023 - 2030, USD Million
TABLE 285 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 286 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 287 LAMEA Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 288 LAMEA Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 289 LAMEA Inflammatory conditions Market by Country, 2019 - 2022, USD Million
TABLE 290 LAMEA Inflammatory conditions Market by Country, 2023 - 2030, USD Million
TABLE 291 LAMEA Multiple sclerosis Market by Country, 2019 - 2022, USD Million
TABLE 292 LAMEA Multiple sclerosis Market by Country, 2023 - 2030, USD Million
TABLE 293 LAMEA Hepatitis C Market by Country, 2019 - 2022, USD Million
TABLE 294 LAMEA Hepatitis C Market by Country, 2023 - 2030, USD Million
TABLE 295 LAMEA Oncology Market by Country, 2019 - 2022, USD Million
TABLE 296 LAMEA Oncology Market by Country, 2023 - 2030, USD Million
TABLE 297 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 298 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 299 LAMEA Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 300 LAMEA Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 301 LAMEA Specialty Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 302 LAMEA Specialty Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 303 LAMEA Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 304 LAMEA Retail Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 305 LAMEA Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 306 LAMEA Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 307 LAMEA Specialty Generics Market by Country, 2019 - 2022, USD Million
TABLE 308 LAMEA Specialty Generics Market by Country, 2023 - 2030, USD Million
TABLE 309 Brazil Specialty Generics Market, 2019 - 2022, USD Million
TABLE 310 Brazil Specialty Generics Market, 2023 - 2030, USD Million
TABLE 311 Brazil Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 312 Brazil Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 313 Brazil Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 314 Brazil Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 315 Brazil Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 316 Brazil Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 317 Argentina Specialty Generics Market, 2019 - 2022, USD Million
TABLE 318 Argentina Specialty Generics Market, 2023 - 2030, USD Million
TABLE 319 Argentina Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 320 Argentina Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 321 Argentina Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 322 Argentina Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 323 Argentina Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 324 Argentina Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 325 UAE Specialty Generics Market, 2019 - 2022, USD Million
TABLE 326 UAE Specialty Generics Market, 2023 - 2030, USD Million
TABLE 327 UAE Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 328 UAE Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 329 UAE Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 330 UAE Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 331 UAE Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 332 UAE Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 333 Saudi Arabia Specialty Generics Market, 2019 - 2022, USD Million
TABLE 334 Saudi Arabia Specialty Generics Market, 2023 - 2030, USD Million
TABLE 335 Saudi Arabia Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 336 Saudi Arabia Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 337 Saudi Arabia Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 338 Saudi Arabia Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 339 Saudi Arabia Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 340 Saudi Arabia Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 341 South Africa Specialty Generics Market, 2019 - 2022, USD Million
TABLE 342 South Africa Specialty Generics Market, 2023 - 2030, USD Million
TABLE 343 South Africa Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 344 South Africa Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 345 South Africa Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 346 South Africa Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 347 South Africa Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 348 South Africa Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 349 Nigeria Specialty Generics Market, 2019 - 2022, USD Million
TABLE 350 Nigeria Specialty Generics Market, 2023 - 2030, USD Million
TABLE 351 Nigeria Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 352 Nigeria Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 353 Nigeria Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 354 Nigeria Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 355 Nigeria Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 356 Nigeria Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 357 Rest of LAMEA Specialty Generics Market, 2019 - 2022, USD Million
TABLE 358 Rest of LAMEA Specialty Generics Market, 2023 - 2030, USD Million
TABLE 359 Rest of LAMEA Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 360 Rest of LAMEA Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 361 Rest of LAMEA Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 362 Rest of LAMEA Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 363 Rest of LAMEA Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 364 Rest of LAMEA Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 365 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 366 Key Information – Novartis AG
TABLE 367 Key Information – Hikma Pharmaceuticals PLC
TABLE 368 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 369 key information – Fresenius SE & Co. KGaA
TABLE 370 key information – Dr. Reddy’s Laboratories Ltd.
TABLE 371 Key information – Mallinckrodt PLC
TABLE 372 key information – Bausch Health Companies, Inc.
TABLE 373 key information – Viatris, Inc.
TABLE 374 Key Information – Apotex, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions: 2020, May – 2023, Jan) Leading Players
FIG 5 Global Specialty Generics Market SHARE by Type, 2022
FIG 6 Global Specialty Generics Market SHARE by Type, 2030
FIG 7 Global Specialty Generics Market by Type, 2019 - 2030, USD Million
FIG 8 Global Specialty Generics Market Share by Application, 2022
FIG 9 Global Specialty Generics Market Share by Application, 2030
FIG 10 Global Specialty Generics Market by Application, 2019 - 2030, USD Million
FIG 11 Global Specialty Generics Market Share by End Use, 2022
FIG 12 Global Specialty Generics Market share by End Use, 2030
FIG 13 Global Specialty Generics Market by End Use, 2019 - 2030, USD Million
FIG 14 Global Specialty Generics Market share by Region, 2022
FIG 15 Global Specialty Generics Market share by Region, 2030
FIG 16 Global Specialty Generics Market by Region, 2019 - 2030, USD Million
FIG 17 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.
FIG 18 Recent strategies and developments: Novartis AG
FIG 19 Recent strategies and developments: Hikma Pharmaceuticals PLC
FIG 20 Recent strategies and developments: Sun Pharmaceutical Industries Ltd.